Modest weight regain after tirzepatide does not undo its metabolic benefits, study finds

A three-year study reveals that slight weight regain following tirzepatide therapy does not significantly diminish its positive effects on blood sugar and other metabolic markers in individuals with obesity and prediabetes. A three-year analysis from the SURMOUNT-1 trial suggests that…















